You can choose the size of the video you would like to embed below. Next, copy the embed code that is available in the box below. Paste this code on to your website to display the video.
If you experience problems embedding videos, please contact us.
May 06, 2014 AT 7:02 AM
American pharmaceutical giant Pfizer reported on Monday quarterly revenue that was shy of Wall Street expectations. Sales of established patented brands and generic drugs declined and so highlighted one reason why Pfizer appears relentless in its pursuit of UK rival AstraZeneca as it seeks ways and means to drive future top and bottom line growth. The approach to AstraZeneca if successful would be the largest acquisition of a British company by a foreign business.